Examples of Temple Agreement in a sentence
Xxxxxx agrees to xxxx or have marked with the Onconova Patents to the extent consistent with applicable Laws any Licensed Product sold by Xxxxxx or by its Sublicensees in accordance with the statutes of any country within the Licensed Territory relating to the marketing of patented articles, including without limitation to the extent required under Section 12.1 of the Temple Agreement.
SymBio agrees to xxxx or have marked with the Onconova Patents to the extent consistent with applicable Laws any Licensed Product sold by SymBio or by its Sublicensees in accordance with the statutes of any country within the Licensed Territory relating to the marketing of patented articles, including without limitation to the extent required under Section 12.1 of the Temple Agreement.
E Mlaki, Project Coordinator, Sengerema Telecentre project, Director Information and Documentation Tanzania Commission for Science and technology13.
The licenses granted by Onconova pursuant to Section 2.1 are, with respect to any Onconova Know-How and Onconova Patents licensed to Onconova under the Temple Agreement, subject to Temple’s reserved rights for non-commercial educational and research purposes under Section 3.1 of the Temple Agreement.
The Parties acknowledge that inventions that are included in the Onconova Patents that are Controlled, but not owned, by Onconova that are licensed to Onconova pursuant to the Temple Agreement may have resulted from United States Government funding, and any such Onconova Patents shall be subject to any applicable Laws of the United States related to federally funded inventions.
The restructuring of the Temple Agreement to include Tuition Assistance.
Each Party acknowledges and agrees that Temple University is a third party beneficiary of this Agreement to the extent required for Temple University to enforce this Agreement against Xxxxxx in its capacity as a sublicensee under the Temple Agreement, and to enforce Temple’s rights under Section 16.2.
Each Party acknowledges and agrees that Temple University is a third party beneficiary of this Agreement to the extent required for Temple University to enforce this Agreement against Baxter in its capacity as a sublicensee under the Temple Agreement, and to enforce Temple’s rights under Section 16.2.
Under the settlement, the parties have entered into a new pharmaceutical use license agreement (New Temple Agreement) that is equivalent in duration and scope to the previous license.
In the end, all the various harms act in concert to have an overall negative effect.